Anti-NF kappa B p105 / p50 (phospho Ser932) Antibody (A93921)

Name: Anti-NF kappa B p105 / p50 (phospho Ser932) Antibody
Brand: Antibodies.com
SKU: A93921
Price: 115.0 GBP
Availability: InStock

Enlarge Image

This product is discontinued

Anti-NF kappa B p105 / p50 (phospho Ser932) Antibody (A93921) has been discontinued and is no longer available.

View all NFkB p50 Antibodies.

Specifications

Name

Anti-NF kappa B p105 / p50 (phospho Ser932) Antibody

Description

Rabbit polyclonal antibody to NF kappa B p105 / p50 (phospho Ser932).

Specificity

This antibody detects endogenous levels of NF-kappaB p105/p50 only when phosphorylated at Ser932.

Applications

WB, ELISA

Dilutions

WB: 1:500~1:1000, IHC: 1:50~1:100, IF: 1:100~1:500, ELISA: 1:40000

Reactivity

Human, Mouse, Rat

Immunogen

Synthetic peptide derived from human NF-kappaB p105/p50 around the phosphorylation site of Ser932 (amino acids 899-948).

Host

Rabbit

Clonality

Polyclonal

Isotype

IgG

Conjugate

Unconjugated

Purification

Purified from rabbit serum by antigen affinity chromatography using the immunizing peptide.

Molecular Weight

105kDa

Product Form

Liquid

Formulation

Supplied in Phosphate Buffered Saline (without Mg2+ and Ca2+), pH 7.4, with 150mM NaCl, 0.02% Sodium Azide, and 50% Glycerol.

Storage

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Synonyms

DNA-binding factor KBF1, EBP-1, NFKB1, Nuclear factor NF-kappa-B p105 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1

Isotype Controls

Suitable Secondaries

See all Anti-Rabbit IgG Secondaries →

Disclaimer

This product is for research use only. It is not intended for diagnostic or therapeutic use.

Scientific Validation DataValidation Data (2)

Enlarge Image

Western Blot - Anti-NF kappa B p105 / p50 (phospho Ser932) Antibody (A93921)

Western blot analysis of lysates from HeLa cells treated with CA+TNF 20ng/ml 10' using Anti-NF kappa B p105 / p50 (phospho Ser932) Antibody. The left hand lane represents a negative control, where the antibody is blocked by the immunising peptide.